PulmonologyNews.net

Pulmonology Xagena

Search results for "Formoterol"

Results from the COSMOS trial demonstrated that Symbicort Single Inhaler Therapy, ( Budesonide / Formoterol maintenance and reliever therapy ), reduces the risk of severe asthma attack by 25 per ce ...


The use of a class of asthma drugs known as long-acting beta-2 agonists is associated with increased risks of asthma-related deaths. The asthma medications are Salmeterol, which is sold under th ...


Little evidence exists to support the widespread use of bronchodilators to treat children and adults with cystic fibrosis. “ Recurrent wheeze and breathlessness are common in people with cystic fib ...


Asthma sufferers who regularly take the beta2-agonist Formoterol ( Foradil ) are more likely to suffer non-fatal serious adverse events than those given placebos. A review carried out by Cochrane Rese ...


Aclidinium bromide ( Eklira, Bretaris ) has been approved since October 2012 for widening the narrowed airways of adults with chronic-obstructive pulmonary disease ( COPD ). The German Institute for Q ...


According to international treatment guidelines, inhaled rapid-acting beta-2 agonists should be used for the control of symptoms in patients with asthma.Researchers have compared the efficacy and safe ...


The SMART ( Single combination budesonide—formoterol inhaler Maintenance And Reliever Therapy ) regimen reduces severe asthma exacerbations in patients, but whether the high doses of corticosteroid an ...


In mild asthma exercise-induced bronchoconstriction is usually treated with inhaled short-acting beta2-agonists ( SABAs ) on demand. The hypothesis was that a combination of Budesonide and Formoter ...


The ACLIFORM/COPD study has assessed the efficacy and safety of two doses of twice-daily ( BID ) Aclidinium bromide / Formoterol fumarate fixed-dose combination ( FDC ) in patients with moderate-to-se ...


Arformoterol tartrate ( Arformoterol, 15 mcg bid; Brovana ) is a nebulized long-acting β2-agonist approved for maintenance treatment of COPD ( chronic obstructive pulmonary disease ). This was a mu ...


Aclidinium bromide / Formoterol fumarate ( 400/12 mcg ) is a fixed dose combination of two approved long-acting bronchodilators with different mechanisms of action and similar pharmocodynamic profiles ...